Pharmaceutical Approval Update.

P T · 2016

Last updated 2026-06-14

Journal	P T, 2016
Citations	0
Relative citation ratio	0.00
NIH percentile	0
Molecules	—

Abstract

Calcifediol (Rayaldee) for secondary hyperparathyroidism in adults with chronic kidney disease; dasabuvir/ombitasvir/paritaprevir/ritonavir (Viekira XR) for hepatitis C virus infection; and lixisenatide (Adlyxin) for type-2 diabetes.

Verbatim abstract via PubMed 27904299 ↗